242 related articles for article (PubMed ID: 3001842)
41. Vasoactive intestinal peptide (VIP) and peptide having N-terminal histidine and C-terminal isoleucine amide (PHI) stimulate adenylate cyclase activity in human heart membranes.
Taton G; Chatelain P; Delhaye M; Camus JC; De Neef P; Waelbroeck M; Tatemoto K; Robberecht P; Christophe J
Peptides; 1982; 3(6):897-900. PubMed ID: 6897744
[TBL] [Abstract][Full Text] [Related]
42. Somatocrinin stimulates adenylate cyclase-Ns regulatory subunit in a GH3 cell-line: comparison with VIP.
Reyl-Desmars F; Zeytin F; Lewin MJ
Peptides; 1986; 7 Suppl 1():165-7. PubMed ID: 2875442
[TBL] [Abstract][Full Text] [Related]
43. Interaction of vasoactive intestinal peptide (VIP) and N-terminally modified VIP analogs with rat pancreatic, hepatic and pituitary membranes.
Robberecht P; Coy DH; De Neef P; Camus JC; Cauvin A; Waelbroeck M; Christophe J
Eur J Biochem; 1986 Aug; 159(1):45-9. PubMed ID: 3017717
[TBL] [Abstract][Full Text] [Related]
44. Growth hormone-releasing hormone is produced by rat Leydig cell in culture and acts as a positive regulator of Leydig cell function.
Ciampani T; Fabbri A; Isidori A; Dufau ML
Endocrinology; 1992 Dec; 131(6):2785-92. PubMed ID: 1332849
[TBL] [Abstract][Full Text] [Related]
45. Receptor-mediated actions of growth hormone releasing factor on granulosa cell differentiation.
Moretti C; Bagnato A; Solan N; Frajese G; Catt KJ
Endocrinology; 1990 Nov; 127(5):2117-26. PubMed ID: 2171907
[TBL] [Abstract][Full Text] [Related]
46. Demonstration of a functional receptor for vasoactive intestinal polypeptide on Molt 4b T lymphoblasts.
Beed EA; O'Dorisio MS; O'Dorisio TM; Gaginella TS
Regul Pept; 1983 Apr; 6(1):1-12. PubMed ID: 6306732
[TBL] [Abstract][Full Text] [Related]
47. Autoradiographic localization of vasoactive intestinal peptide (VIP) binding sites in the human term placenta. Relationship with activation of adenylate cyclase.
Besson J; Malassiné A; Ferré F
Regul Pept; 1987 Nov; 19(3-4):197-207. PubMed ID: 2829291
[TBL] [Abstract][Full Text] [Related]
48. The somatostatin receptor is directly coupled to adenylate cyclase in GH4C1 pituitary cell membranes.
Koch BD; Schonbrunn A
Endocrinology; 1984 May; 114(5):1784-90. PubMed ID: 6143660
[TBL] [Abstract][Full Text] [Related]
49. Vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide receptor chimeras reveal domains that determine specificity of vasoactive intestinal polypeptide binding and activation.
Hashimoto H; Ogawa N; Hagihara N; Yamamoto K; Imanishi K; Nogi H; Nishino A; Fujita T; Matsuda T; Nagata S; Baba A
Mol Pharmacol; 1997 Jul; 52(1):128-35. PubMed ID: 9224822
[TBL] [Abstract][Full Text] [Related]
50. Vasoactive intestinal polypeptide receptor VPAC(1) subtype is predominant in rat prostate membranes.
Juarranz MG; De Neef P; Robberecht P
Prostate; 1999 Sep; 41(1):1-6. PubMed ID: 10440869
[TBL] [Abstract][Full Text] [Related]
51. High affinity vasoactive intestinal peptide receptors on fetal human nonpigmented ciliary epithelial cells.
Crook RB; Lui GM; Alvarado JA; Fauss DJ; Polansky JR
Curr Eye Res; 1994 Apr; 13(4):271-9. PubMed ID: 8033589
[TBL] [Abstract][Full Text] [Related]
52. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
[TBL] [Abstract][Full Text] [Related]
53. Actions of VIP, hGRF, PHI and secretin: comparative studies in cerebral cortex and adenohypophysis.
Magistretti PJ; Schönenberg P; Kehrer P; Martin JL; Gaillard RC
Peptides; 1986; 7 Suppl 1():175-80. PubMed ID: 3018695
[TBL] [Abstract][Full Text] [Related]
54. Characterization of vasoactive intestinal peptide/pituitary adenylate cyclase-activating polypeptide receptors in chick cerebral cortex.
Zawilska JB; Niewiadomski P; Nowak JZ
J Mol Neurosci; 2003 Apr; 20(2):153-62. PubMed ID: 12794309
[TBL] [Abstract][Full Text] [Related]
55. Properties of vasoactive-intestinal-peptide receptors and beta-adrenoceptors in the murine radiation leukemia-virus-induced lymphoma cell line BL/VL3.
Abello J; Damien C; De Neef P; Tastenoy M; Hooghe R; Robberecht P; Christophe J
Eur J Biochem; 1989 Aug; 183(2):263-7. PubMed ID: 2547606
[TBL] [Abstract][Full Text] [Related]
56. Specific labelling by [125I]helodermin of high-affinity VIP receptors in rat liver membranes.
Robberecht P; Waelbroeck M; de Neef P; Camus JC; Vandermeers A; Vandermeers-Piret MC; Christophe J
FEBS Lett; 1984 Jun; 172(1):55-8. PubMed ID: 6329822
[TBL] [Abstract][Full Text] [Related]
57. Comparison of VIP-secretin receptors in rat and human lung.
Christophe J; Chatelain P; Taton G; Delhaye M; Waelbroeck M; Robberecht P
Peptides; 1981; 2 Suppl 2():253-8. PubMed ID: 6123988
[TBL] [Abstract][Full Text] [Related]
58. Antagonistic actions of analogs related to growth hormone-releasing hormone (GHRH) on receptors for GHRH and vasoactive intestinal peptide on rat pituitary and pineal cells in vitro.
Rekasi Z; Varga JL; Schally AV; Halmos G; Groot K; Czompoly T
Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1218-23. PubMed ID: 10655511
[TBL] [Abstract][Full Text] [Related]
59. Covalent cross-linking of vasoactive intestinal polypeptide to its receptors on intact human lymphoblasts.
Wood CL; O'Dorisio MS
J Biol Chem; 1985 Jan; 260(2):1243-7. PubMed ID: 2981838
[TBL] [Abstract][Full Text] [Related]
60. Characterization of receptors for vasoactive intestinal peptide solubilized from the lung.
Paul S; Said SI
J Biol Chem; 1987 Jan; 262(1):158-62. PubMed ID: 3025200
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
